Sufentanil Citrate Injection Shortage

Last Updated: August 15, 2025
Status: Current

Unavailable, Current:

• Sufentanil Citrate, Injection, 50 mcg/1 mL (Hikma Pharmaceuticals USA, Inc.)

Available, Current:

• Sufentanil Citrate, Injection, 50 ug/1 mL (Hospira, Inc., a Pfizer Company)

Sufentanil Citrate, Injection, 50 mcg/1 mL (Hikma Pharmaceuticals USA, Inc.)

NDC Code: 17478-050-01
Availability: Unavailable
Status: Current
Date of update: July 23, 2025
Update type: Reverified
Reason for shortage: Other
Related Information: Not currently manufactured
Therapeutic category: Analgesia/Addiction; Pediatric
Initial posting date: May 3, 2022
Contact info: 800-631-2174

Sufentanil Citrate, Injection, 50 mcg/1 mL (Hikma Pharmaceuticals USA, Inc.)

NDC Code: 17478-050-02
Availability: Unavailable
Status: Current
Date of update: July 23, 2025
Update type: Revised
Reason for shortage: Other
Related Information: Not currently manufactured
Therapeutic category: Analgesia/Addiction; Pediatric
Initial posting date: May 3, 2022
Contact info: 800-631-2174

Sufentanil Citrate, Injection, 50 mcg/1 mL (Hikma Pharmaceuticals USA, Inc.)

NDC Code: 17478-050-05
Availability: Unavailable
Status: Current
Date of update: July 23, 2025
Update type: Revised
Reason for shortage: Other
Related Information: Not currently manufactured
Therapeutic category: Analgesia/Addiction; Pediatric
Initial posting date: May 3, 2022
Contact info: 800-631-2174

Sufentanil Citrate, Injection, 50 ug/1 mL (Hospira, Inc., a Pfizer Company)

NDC Code: 0409-3382-21
Availability: Available
Status: Current
Date of update: August 15, 2025
Update type: Revised
Therapeutic category: Analgesia/Addiction; Pediatric
Initial posting date: May 3, 2022
Contact info: 844-646-4398

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer